Search Results - "Unterecker, S."

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017 by Hiemke, C, Bergemann, N, Clement, H W, Conca, A, Deckert, J, Domschke, K, Eckermann, G, Egberts, K, Gerlach, M, Greiner, C, Gründer, G, Haen, E, Havemann-Reinecke, U, Hefner, G, Helmer, R, Janssen, G, Jaquenoud, E, Laux, G, Messer, T, Mössner, R, Müller, M J, Paulzen, M, Pfuhlmann, B, Riederer, P, Saria, A, Schoppek, B, Schoretsanitis, G, Schwarz, M, Gracia, M Silva, Stegmann, B, Steimer, W, Stingl, J C, Uhr, M, Ulrich, S, Unterecker, S, Waschgler, R, Zernig, G, Zurek, G, Baumann, P

“…Therapeutic drug monitoring (TDM) is the quantification and interpretation of drug concentrations in blood to optimize pharmacotherapy. It considers the…”
Get more information

Effects of gender and age on serum concentrations of antidepressants under naturalistic conditions by Unterecker, S., Riederer, P., Proft, F., Maloney, J., Deckert, J., Pfuhlmann, B.

“…Therapeutic drug monitoring (TDM) data of antidepressant drugs are often evaluated using homogeneous samples of selected individuals without psychiatric or…”
Get full text

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants by Eap, C. B., Gründer, G., Baumann, P., Ansermot, N., Conca, A., Corruble, E., Crettol, S., Dahl, M. L., de Leon, J., Greiner, C., Howes, O., Kim, E., Lanzenberger, R., Meyer, J. H., Moessner, R., Mulder, H., Müller, D. J., Reis, M., Riederer, P., Ruhe, H. G., Spigset, O., Spina, E., Stegman, B., Steimer, W., Stingl, J., Suzen, S., Uchida, H., Unterecker, S., Vandenberghe, F., Hiemke, C.

“…Objectives: More than 40 drugs are available to treat affective disorders. Individual selection of the optimal drug and dose is required to attain the highest…”
Get full text

Elevated clozapine serum levels in combination with perazine by Fischer, M., Unterecker, S., Deckert, J., Pfuhlmann, B.

Get full text

Correlation of QTc interval prolongation and serum level of citalopram after intoxication--a case report by Unterecker, S, Warrings, B, Deckert, J, Pfuhlmann, B

“…Citalopram (CIT) is a widely used antidepressant which acts by a selective serotonin reuptake inhibition. It is considered to be safer than tricyclic…”
Get more information

Antidepressant effects of augmentative transcranial magnetic stimulation: Randomised multicentre trial by HERWIG, UWE, FALLGATTER, ANDREAS J, HOPPNER, JACQUELINE, ESCHWEILER, GERHARD W, KRON, MARTINA, HAJAK, GORAN, PADBERG, FRANK, NADERI-HEIDEN, ANGELA, ABLER, BIRGIT, EICHHAMMER, PETER, GROSSHEINRICH, NICOLA, HAY, BIRGIT, KAMMER, THOMAS, LANGGUTH, BERTHOLD, LASKE, CHRISTOPH, PLEWNIA, CHRISTIAN, RICHTER, MELANY M, SCHULZ, MERTEN, UNTERECKER, STEFAN, ZINKE, ANTONIA, SPITZER, MANFRED, SCHONFELDT-LECUONA, CARLOS

“…Repetitive transcranial magnetic stimulation (rTMS) has been proposed as a new treatment option for depression. Previous studies were performed with low sample…”
Get full text

The effect of age, sex, smoking and co-medication on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditions by Unterecker, S, Hiemke, C, Greiner, C, Haen, E, Jabs, B, Deckert, J, Pfuhlmann, B

“…Venlafaxine (VEN) is a modern antidepressant which exerts both serotonin and norepinephrine reuptake inhibition. In this study we examined the influence of…”
Get more information

EPA-1097 - False positive phencyclidine drug screenings during psychopharmacologic treatment by Fischer, M, Unterecker, S, Deckert, J

“…Introduction False-positive drug screenings have been reported for several drugs and can affect the therapeutic relationship. Objective We wanted to find out,…”
Get full text

Retrospective pilot study for analysis of antidepressant serum concentrations of citalopram and venlafaxine during inflammation by Hefner, G, Shams, M E E, Unterecker, S, Falter, T, Hiemke, C

“…Inflammation-mediated changes in drug metabolism may increase drug levels in blood and lead to intoxications. The objective of this study was to find out…”
Get more information

SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcome by Proft, F, Kopf, J, Olmes, D, Hempel, S, Schmidt, B, Riederer, P, Deckert, J, Pfuhlmann, B, Reif, A, Unterecker, S

“…The effects of genetic variants in genes encoding the target structures of antidepressants on the therapeutic efficacy of antidepressant drugs have been…”
Get more information

Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice by Pfuhlmann, B, Gerlach, M, Burger, R, Gonska, S, Unterecker, S, Jabs, B, Riederer, P, Deckert, J

“…Data about therapeutic drug monitoring (TDM) of psychotropic medications are often obtained from samples of highly selected individuals, who may not be…”
Get more information

Therapeutic drug level measurement in breast milk by Kittel-Schneider, S., Preis, K., Menke, A., Unterecker, S., Deckert, J., Reif, A.

Get full text

Therapeutic Drug Monitoring of Antidepressants for the Treatment of Chronic Musculoskeletal Pain With and Without Depression by Scherf-Clavel, Maike, Breisinger, Sarah, Fischer, Monika, Deckert, Jürgen, Unterecker, Stefan, Rittner, Heike L.

“…Antidepressants are recommended for the treatment of chronic musculoskeletal pain; however, target serum concentrations based on therapeutic drug monitoring…”
Get full text

Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics by Hart, Xenia Marlene, Gründer, Gerhard, Ansermot, Nicolas, Conca, Andreas, Corruble, Emmanuelle, Crettol, Severine, Cumming, Paul, Hefner, Gudrun, Frajerman, Ariel, Howes, Oliver, Jukic, Marin M, Kim, Euitae, Kim, Seoyoung, Maniscalco, Ignazio, Moriguchi, Sho, Müller, Daniel J, Nakajima, Shinichiro, Osugo, Martin, Paulzen, Michael, Ruhe, Henricus Gerardus, Scherf-Clavel, Maike, Schoretsanitis, Georgios, Serretti, Alessandro, Spina, Edoardo, Spigset, Olav, Steimer, Werner, Süzen, Sinan H, Uchida, Hiroyuki, Unterecker, Stefan, Vandenberghe, Frederik, Verstuyft, Celine, Zernig, Gerald, Hiemke, Christoph, Eap, Chin B

“…For psychotic disorders (i.e. schizophrenia), pharmacotherapy plays a key role in controlling acute and long-term symptoms. To find the optimal individual dose…”
Get full text

False-positive phencyclidine drug screenings during psychopharmacologic treatment by Fischer, Matthias, Unterecker, Stefan, Deckert, Jürgen

Get full text

Reduced response-inhibition in obsessive–compulsive disorder measured with topographic evoked potential mapping by Herrmann, Martin J., Jacob, Christian, Unterecker, Stefan, Fallgatter, Andreas J.

“…Recent neuroimaging studies have suggested that a hyperactivity of the frontal-striate neuronal circuits, including the orbitofrontal cortex and the basal…”
Get full text

Antidepressant effects of augmentative transcranial magnetic stimulation : Randomised multicentre trial by HERWIG, U, FALLGATTER, A. J, GROSSHEINRICH, N, HAY, B, KAMMER, T, LANGGUTH, B, LASKE, C, PLEWNIA, C, RICHTER, M. M, SCHULZ, M, UNTERECKER, S, ZINKE, A, HÖPPNER, J, SPITZER, M, SCHÖNFELDT-LECUONA, C, ESCHWEILER, G. W, KRON, M, HAJAK, G, PADBERG, F, NADERI-HEIDEN, A, ABLER, B, EICHHAMMER, P

Get full text